Home | Welcome to Contract Pharma   
Last Updated Monday, December 22 2014

Print RSS Feed

Topics - Inspections


Refine by Date:
From: To:
Published December 17, 2014
Site compliant with GMP but Form 483 notes three inspectional observations Read More »
Published September 4, 2014
Complies with the quality GMP & GDP standards Read More »
Published September 3, 2014
Will test commercial drug product for the European market Read More »
Published August 18, 2014
To manufacture API for branded commercial drug Read More »
Published August 5, 2014
Ireland facility gains pre-approval Read More »
Published July 22, 2014
Will produce NME for U.S. market Read More »
Published July 8, 2014
Gains certification by Belgium and EU authorities Read More »
Published July 8, 2014
Inspection covered quality system and lab facilities in Torrance, CA Read More »
Published June 26, 2014
Enables CTM services in more than 44 Asian countries Read More »
Published June 12, 2014
Will manufacture Phase IIb batches of Ovasave for Crohn’s trial Read More »
Published June 5, 2014
Will reinstate GMP certificate Read More »
Published May 21, 2014
Suzhou site successfully passes three GLP inspections Read More »
Published April 30, 2014
Analytical and stability testing, and CTM services deemed compliant Read More »
By Kristin Brooks
Published March 27, 2014
Areas of toxicity, mutagenicity, analytical and clinical chemistry testing in compliance Read More »
By Kristin Brooks
Published February 11, 2014
Quality Control testing and release Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On